
AstraNu
AstraNu builds compact, low‑cost optical coherence tomography devices for clinicians and patients.
AstraNu is a hardware & semiconductors company based in Murray Hill, US, founded in 2025. It has raised $3.5 million in disclosed funding. Its latest round was a Seed of $3.5 million in November 2026.
Overview
AstraNu develops an integrated optical coherence tomography (OCT) platform that brings high‑performance imaging to a fraction of the size and cost of traditional systems. Leveraging photonics expertise from Nokia Bell Labs, the chip‑scale device combines telecom‑grade components with medical‑imaging algorithms, enabling clinicians to obtain detailed cross‑sectional images at the point of care. The company targets hospitals, ophthalmology clinics and other diagnostic centers that need affordable, portable imaging tools, aiming to improve patient outcomes by expanding access to OCT. AstraNu sells the hardware as a turnkey solution and plans to offer service and software updates on a recurring basis. Founded in 2025, the startup has raised $3.5 million in a seed round and is classified in the hardware and health‑tech sectors. The team includes founders with PhDs in optoelectronics and a leadership group drawn from life‑science and telecom backgrounds. [0]
Funding
Total disclosed: $3.5M across 1 round. Computed only from sourced rounds.
Investors
In the news

Questions and answers
What does AstraNu do?
AstraNu builds compact, low‑cost optical coherence tomography devices for clinicians and patients.
How much has AstraNu raised?
AstraNu has raised $3.5 million in disclosed funding across 1 round tracked by OSH.
Who has invested in AstraNu?
Investors in AstraNu include Celesta and New Jersey Innovation Evergreen Fund.
When and where was AstraNu founded?
AstraNu was founded in 2025 and is based in Murray Hill, US.
Timeline
Founded
Sources
- 1.AstraNu Closes $3.5 Million Seed Round Led by Celesta Capital to Commercialize Chip-Scale Optical Imaging Engine — prnewswire.com · Press release
- 2.AstraNu · Official